Statistics
Publications
27
Citations
1.9K
H-Index
17
Active since
2006
Alvaro J. Alencar is an author at Sylvester Comprehensive Cancer Center specializing in medicine, oncology, and tyrosine kinase inhibitors.
Publications per year
2006–2024
27
27
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
Anthony R. Mato, Nirav N. Shah, Wojciech Jurczak et al. · The Lancet · 2021 · 454 citations · Full text
Medicine, Oncology, Pharmacology +12
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127
Skye Montoya, Jessie Bourcier, Mark Noviski et al. · Science · 2024 · 148 citations · Full text
1–5 of 27